Assessment of a High Sensitivity Method for Identification of <i>IDH1</i> R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients
Hotspot codon 132 mutations (R132x<i>IDH1</i>m) are frequent in intrahepatic cholangiocarcinoma (ICC), are druggable by anti-<i>IDH1</i>m agents, and could represent a marker of disease progression. Developing an assay to identify R132x<i>IDH1</i>m would provide a...
Main Authors: | Caterina Peraldo-Neia, Maria Scatolini, Enrico Grosso, Pasquale Lombardi, Roberto Filippi, Chiara Raggi, Caterina Marchiò, Giuliana Cavalloni, Massimo Aglietta, Francesco Leone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/4/454 |
Similar Items
-
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma
by: C. Peraldo-Neia, et al.
Published: (2018-06-01) -
A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient
by: Caterina Peraldo-Neia, et al.
Published: (2021-04-01) -
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
by: Giuliana Cavalloni, et al.
Published: (2021-07-01) -
<i>IDH1</i> Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
by: Fabiana Crispo, et al.
Published: (2020-08-01) -
Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies
by: Samantha M. Ruff, et al.
Published: (2024-01-01)